Difluoromethylornithine (DFMO) and Neuroblastoma: A Review-Reference-Cited by-同舟云学术

Difluoromethylornithine (DFMO) and Neuroblastoma: A Review

Published:2023-04-17 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Tangella Adarsh Vardhan,Gajre Ashwin S,Chirumamilla Punith Chowdary,Rathhan Pemma V

Publisher

Springer Science and Business Media LLC

Subject

Aerospace Engineering

Reference58 articles.

1. American Cancer Society. Neuroblastoma. (2020). Accessed: March 28, 2023: https://www.cancer.org/cancer/neuroblastoma/about/key-statistics.html.

2. National Cancer Institute. Neuroblastoma Treatment (PDQ®)-Patient Version. (2022). Accessed. March 28, 2023: https://www.cancer.gov/types/neuroblastoma/patient/neuroblastoma-treatment-pdq.

3. Neuroblastoma;Maris JM;Lancet,2007

4. Neuroblastoma;Matthay KK;Nat Rev Dis Primers,2016

5. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report;Cohn SL;J Clin Oncol,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of thermophysical properties on eflornithine drug solute in acetone and ethyl acetate solvent interactions at varying concentrations and temperatures;BMC Chemistry;2024-08-16

2. Disrupting YAP1-mediated glutamine metabolism induces synthetic lethality alongside ODC1 inhibition in osteosarcoma;Cellular Oncology;2024-08-08

3. Mechanistic insights into medulloblastoma relapse;Pharmacology & Therapeutics;2024-08

4. Decoding the tumour-modulatory roles of LIMK2;Life Sciences;2024-06

5. Opaganib Downregulates N-Myc Expression and Suppresses In Vitro and In Vivo Growth of Neuroblastoma Cells;Cancers;2024-05-05